Viewing Study NCT05113095


Ignite Creation Date: 2025-12-24 @ 1:28 PM
Ignite Modification Date: 2026-01-01 @ 7:33 PM
Study NCT ID: NCT05113095
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2021-11-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Survey of Darvadstrocel in People With Crohn's Disease
Sponsor: Takeda
Organization:

Study Overview

Official Title: Postmarketing Surveillance Registry to Evaluate Safety and Efficacy of Darvadstrocel for the Treatment of Complex Perianal Fistulas in Crohn's Disease Patients (J-INSPIRE) (All-case Surveillance)
Status: RECRUITING
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: J-INSPIRE
Brief Summary: This study is a survey in Japan of Darvadstrocel injection used to treat Crohn's disease people with complicated anal fistula. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study.

The main aim of the study is to check for side effects related from Darvadstrocel injection and to check if Darvadstrocel injection improves symptoms of Crohn's disease. During the study, participants with Crohn's disease will take Darvadstrocel injection according to their clinic's standard practice. The study doctors will check for side effects from Darvadstrocel for 36 months.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
jRCT2033210424 REGISTRY jRCT View